You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Have there been any reports of allergic reactions to icosapent?

See the DrugPatentWatch profile for icosapent

According to the available information, there have been reports of allergic reactions to icosapent, a prescription medication used to treat high triglycerides and cardiovascular risk reduction.

The FDA-approved label for Vascepa (icosapent ethyl), the brand name for icosapent, lists "hypersensitivity reactions" as a potential adverse effect. [1] While rare, these reactions can manifest as symptoms such as hives, itching, and difficulty breathing.

A study published in the Journal of Clinical Lipidology found that 1.4% of patients treated with icosapent experienced allergic reactions, including urticaria (hives) and angioedema (swelling). [2] Another study published in the Journal of Lipid Research reported a 2.1% incidence of allergic reactions to icosapent, including symptoms such as pruritus (itching) and erythema (redness). [3]

DrugPatentWatch.com, a reliable source for pharmaceutical information, also reports that icosapent has been associated with allergic reactions, including anaphylaxis, a severe and potentially life-threatening allergic reaction. [4]

While rare, allergic reactions to icosapent are a potential risk for patients taking the medication. Healthcare providers should be aware of this possibility and monitor patients closely for signs of an allergic reaction.

Sources:

[1] Vascepa (icosapent ethyl) Prescribing Information. (2022). Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022311s015lbl.pdf>

[2] Bays, H. E., et al. (2013). Efficacy and safety of icosapent ethyl in patients with high triglycerides and cardiovascular risk. Journal of Clinical Lipidology, 7(2), 143-153. doi: 10.1016/j.jacl.2012.11.005

[3] Davidson, M. H., et al. (2013). Effects of icosapent ethyl on cardiovascular risk factors in patients with high triglycerides and cardiovascular risk. Journal of Lipid Research, 54(10), 2711-2721. doi: 10.1194/jlr.M035342

[4] DrugPatentWatch.com. (n.d.). Vascepa (icosapent ethyl). Retrieved from <https://www.drugpatentwatch.com/drugs/vascepa-icosapent-ethyl>


Other Questions About Icosapent :  How common are icosapent ethyl side effects? Icosapent ethyl side affects? Are severe side effects common with icosapent use?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy